Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Annette R. Kodahl"'
Autor:
Odd L. Gammelgaard, Mikkel G. Terp, Alexei F. Kirkin, Simone Johansen, Sofie Traynor, Henriette Vever, Per Guldberg, Annette R. Kodahl, Morten F. Gjerstorff, Henrik J. Ditzel
Publikováno v:
Molecular Cancer, Vol 23, Iss 1, Pp 1-16 (2024)
Abstract Background Adoptive cell transfer cancer immunotherapy holds promise for treating disseminated disease, yet generating sufficient numbers of lymphocytes with anti-cancer activity against diverse specificities remains a major challenge. We re
Externí odkaz:
https://doaj.org/article/b15051babf3e4694bceb90e2ee16d652
Autor:
Annette R. Kodahl, Sidse Ehmsen, Niels Pallisgaard, Anne M. B. Jylling, Jeanette D. Jensen, Anne‐Vibeke Lænkholm, Ann S. Knoop, Henrik J. Ditzel
Publikováno v:
Molecular Oncology, Vol 12, Iss 6, Pp 925-935 (2018)
Liquid biopsies focusing on the analysis of cell‐free circulating tumor DNA (ctDNA) may have important clinical implications for personalized medicine, including early detection of cancer, therapeutic guidance, and monitoring of recurrence. Mutatio
Externí odkaz:
https://doaj.org/article/25c7104ef4c446408cd90a879f5ba181
Autor:
Andreas Glenthøj, Lasse H. Jakobsen, Mads Emil Bjørn, Christian B. Poulsen, Henrik Sengeløv, Marianne T. Severinsen, Kristian Qvist, Ulrik M. Overgaard, Syed A. Ahmad, Annika Rewes, Ingolf Mølle, Casper N. Strandholdt, Annette R. Kodahl, Jesper Ryg, Christian Brieghel, Isik S. Johansen, Karina Kannik, Søren Jensen-Fangel, Lothar Wiese, Ole Kirk, Michael R. Clausen, Marie Helleberg, Henrik Frederiksen
Publikováno v:
Glenthøj, A, Jakobsen, L H, Bjørn, M E, Poulsen, C B, Sengeløv, H, Severinsen, M T, Qvist, K, Overgaard, U M, Ahmad, S A, Rewes, A, Mølle, I, Strandholdt, C N, Kodahl, A R, Ryg, J, Brieghel, C, Johansen, I S, Kannik, K, Jensen-Fangel, S, Wiese, L, Kirk, O, Clausen, M R, Helleberg, M & Frederiksen, H 2022, ' Severity and 90-day survival of SARS-CoV-2 infection among patients with haematological disorders ', Acta Oncologica, vol. 61, no. 4, pp. 500-504 . https://doi.org/10.1080/0284186X.2022.2026464
Severity and 90-day survival of SARS-CoV-2 infection among patients with haematological disorders
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f06544458e00e3b4c7dd920412ecd3ed
https://pure.au.dk/portal/da/publications/severity-and-90day-survival-of-sarscov2-infection-among-patients-with-haematological-disorders(07e1b21b-09f9-45d5-b2fa-be740fc8221e).html
https://pure.au.dk/portal/da/publications/severity-and-90day-survival-of-sarscov2-infection-among-patients-with-haematological-disorders(07e1b21b-09f9-45d5-b2fa-be740fc8221e).html
Autor:
Kristoffer B Kristensen, Tobias Berg, Anders Bonde Jensen, Annette R Kodahl, Ida Marie Nedergaard Thomsen
Publikováno v:
Kristensen, K B, Thomsen, I M N, Berg, T, Kodahl, A R & Jensen, A B 2021, ' Dose modifications of ribociclib and endocrine therapy for treatment of ER+ HER2− metastatic breast cancer ', Breast Cancer Research and Treatment, vol. 188, no. 3, pp. 799-809 . https://doi.org/10.1007/s10549-021-06215-6
Purpose: Treatment for estrogen receptor positive (ER+), human epidermal receptor 2 negative (HER2−) metastatic breast cancer (MBC) has improved with the approval of CDK 4/6 inhibitors. Clinical trials with the CDK4/6 inhibitor ribociclib, suggest
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b950a1d8e1a8fdcfe66c80e4a1446ed5
https://pure.au.dk/portal/da/publications/dose-modifications-of-ribociclib-and-endocrine-therapy-for-treatment-of-er-her2-metastatic-breast-cancer(0164b09a-6bd1-4631-a210-2690c5b476d0).html
https://pure.au.dk/portal/da/publications/dose-modifications-of-ribociclib-and-endocrine-therapy-for-treatment-of-er-her2-metastatic-breast-cancer(0164b09a-6bd1-4631-a210-2690c5b476d0).html
Clinical Impact of FDG-PET/CT Compared with CE-CT in Response Monitoring of Metastatic Breast Cancer
Autor:
Jakob Lykke Bülow, Hjalte Rasmus Oltmann, Tural Asgharzadeh Alamdari, Malene Hildebrandt, Marianne Vogsen, Mohammad Naghavi-Behzad, Lasse Ljungstrøm, Oke Gerke, Poul-Erik Braad, Jon Thor Asmussen, Annette R Kodahl
Publikováno v:
Cancers, Vol 13, Iss 4080, p 4080 (2021)
Cancers
Naghavi-Behzad, M, Oltmann, H R, Alamdari, T A, Bülow, J L, Ljungstrøm, L, Braad, P-E, Asmussen, J T, Vogsen, M, Kodahl, A R, Gerke, O & Hildebrandt, M G 2021, ' Clinical Impact of FDG-PET/CT Compared with CE-CT in Response Monitoring of Metastatic Breast Cancer ', Cancers, vol. 13, no. 16, 4080 . https://doi.org/10.3390/cancers13164080
Volume 13
Issue 16
Cancers
Naghavi-Behzad, M, Oltmann, H R, Alamdari, T A, Bülow, J L, Ljungstrøm, L, Braad, P-E, Asmussen, J T, Vogsen, M, Kodahl, A R, Gerke, O & Hildebrandt, M G 2021, ' Clinical Impact of FDG-PET/CT Compared with CE-CT in Response Monitoring of Metastatic Breast Cancer ', Cancers, vol. 13, no. 16, 4080 . https://doi.org/10.3390/cancers13164080
Volume 13
Issue 16
We compared response categories and impacts on treatment decisions for metastatic breast cancer (MBC) patients that are response-monitored with contrast-enhanced computed-tomography (CE-CT) or fluorodeoxyglucose-positron emission tomography/computed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac6c05cc4af25a669f85bcb828d7d347
https://www.mdpi.com/2072-6694/13/16/4080
https://www.mdpi.com/2072-6694/13/16/4080
Autor:
Kristoffer Bøss Kristensen, Ida Marie Nedergaard Thomsen, Tobias Berg, Annette R. Kodahl, Anders B. Jensen
Purpose: Treatment for estrogen receptor positive (ER+), human epidermal receptor 2 negative (HER2-) metastatic breast cancer (MBC) has improved with the approval of CDK 4/6 inhibitors. Clinical trials with the CDK4/6 inhibitor ribociclib, suggest th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f0ac278b7c96fd486448e3e9fb605cfa
https://doi.org/10.21203/rs.3.rs-215362/v1
https://doi.org/10.21203/rs.3.rs-215362/v1
Autor:
Sidse Ehmsen, Anne Vibeke Lænkholm, Niels Pallisgaard, Anne Marie Bak Jylling, Annette R Kodahl, Jeanette Dupont Jensen, Ann Knoop, Henrik J. Ditzel
Publikováno v:
Molecular Oncology. 12:925-935
Liquid biopsies focusing on the analysis of cell-free circulating tumor DNA (ctDNA) may have important clinical implications for personalized medicine, including early detection of cancer, therapeutic guidance, and monitoring of recurrence. Mutations
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d2524fbb5a7282128e7bfb9778b5b504
https://doi.org/10.1002/1878-0261.12305
https://doi.org/10.1002/1878-0261.12305
Publikováno v:
Annals of Oncology. 32:S71
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ad3041e50149d9dbd70ab4950fd0bccd
https://doi.org/10.1016/j.annonc.2021.03.128
https://doi.org/10.1016/j.annonc.2021.03.128
Autor:
Ole Mogensen, Malene Hildebrandt, Pernille Tine Jensen, Annette R Kodahl, Dorte Teilmann-Jørgensen
Publikováno v:
PET Clinics. 10:89-104
In this literature review, an update is provided on the role of [(18)F]fluorodeoxyglucose PET/computed tomography in different clinical settings of the 4 most frequent female-specific cancer types: breast, endometrial, ovarian, and cervical cancer. T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2185d01ff7bb4c404b48cbb1bd20d0ea
https://doi.org/10.1016/j.cpet.2014.09.007
https://doi.org/10.1016/j.cpet.2014.09.007
Autor:
Panpan Wang, Tse Hui Lim, Henrik J. Ditzel, Min Feng, Soo-Chin Lee, Annette R Kodahl, Suman Sarma, Gokce Oguz, Qiang Yu, Siti Maryam J M Yatim, Wenyu Wang, Ern Yu Tan, Selena Y. Lin, Alvin Soon Tiong Lim, Alexander Lezhava, Jian Yuan Goh, Dave S.B. Hoon, Yoon Sim Yap, Maria Bibi Lyng, Wai Leong Tam, Puay Leng Lee, Yi Bao
Publikováno v:
Goh, J Y, Feng, M, Wang, W, Oguz, G, Yatim, S M J M, Lee, P L, Bao, Y, Lim, T H, Wang, P, Tam, W L, Kodahl, A R, Lyng, M B, Sarma, S, Lin, S Y, Lezhava, A, Yap, Y S, Lim, A S T, Hoon, D S B, Ditzel, H J, Lee, S C, Tan, E Y & Yu, Q 2017, ' Chromosome 1q21.3 amplification is a trackable biomarker and actionable target for breast cancer recurrence ', Nature Medicine, vol. 23, no. 11, pp. 1319–1330 . https://doi.org/10.1038/nm.4405
Tumor recurrence remains the main reason for breast cancer-associated mortality, and there are unmet clinical demands for the discovery of new biomarkers and development of treatment solutions to benefit patients with breast cancer at high risk of re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::756a8bc76102d1ecaf686f4f5f91d4f4
https://pubmed.ncbi.nlm.nih.gov/28967919
https://pubmed.ncbi.nlm.nih.gov/28967919